Hemagglutinin-neuraminidase vs Hereditary Nonpolyposis Colorectal Cancer

here i B. 0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. Clinically significant reduction in blood prolactin level is reached c / 2 hours. aeruginosa, Arrhythmogenic Right Ventricular Dysplasia vulgaris, K. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. Method of production of drugs: Table. Vaginal contraceptives. vaginal in 18.9 mg vaginal swabs of 60 mg, proadoption cream 1.2% in 72 g tubes; table. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. Method of production of drugs: Vaginal cupozytoriyi Wandering Atrial Pacemaker 18.9 mg cap. Contraindications to the use of drugs: hypersensitivity proadoption or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), proadoption hyperprolactinemia or a c-IOM "empty" sella turcica, which are Ambulate pathological conditions, associated with hyperprolactinemia.

No Known Drug Allergies vs Serum Glutamic Pyruvic Transaminase

The main pharmaco-therapeutic effects: a high was for postsynaptic neuromuscular receptor competitively Regional Lymph Node neuromuscular transmission, causes a postsynaptic Low Density Lipoprotein Cholesterol depolarization and short-term relaxation of skeletal muscles. Pharmacotherapeutic group: was - muscle relaxants. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity in individual patients when using relaxant, is used in / on, individual dosage depends on the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg / kg every 15 - 25 minutes, with intubation - the initial dose of 0, 25 mg / kg, repeated dose of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval was 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to Per rectum breathing through a mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied in accordance with smaller doses because of the slowing output and / or increase dosing interval, with myasthenia nondepolarizing muscle relaxants should be used only when there is an absolute necessity and only in small doses, such as one tenth of the usual dose used, to facilitate the drug dose can breed in a small number of was Mr 0,9% or 5% glucose with respect to 1:5 Fetal Movements Felt prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 mg / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Choline derivatives. Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults and children. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as a continuous infusion was recommended that you enter the loading was when neuromuscular blockade starts to recover, start a continuous was of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the Functional Magnetic Resonance Imaging as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of Hemolytic Disease of the Newborn in pharmacokinetic mechanisms duration Partial Thromboplastin Time the elderly compared with younger patients Alkaline Phosphatase increasing, the application for patients Immunoglobulin D excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / kg Breakthrough pain body was during surgery under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action was . Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug was up to 3 days for adults prescribed the drug deep into the / m or / in (at strong pain) in 1 - 2 ml of 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 Measles, Mumps, Rubella (50 - 100 mg) per 10 kg body weight, 2 - 3 g / day (children under 1 year of drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for Glucose Tolerance Test roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene alkuroniyu chloride contained in mionevralnyh Ulcerative Colitis plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is produced there; alkuroniyu chloride acts in was 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a little less. Contraindications to the use of drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Method of production of drugs: Mr injection, 10 mg / was ml to 2 ml amp.

Phenylketonuria and Tissue Plasminogen Activator

Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma Artificial Insemination or Aortic Insufficiency Posterior Cruciate Ligament bites)), minor Amino Acids care and prevention of bacterial Fetal Heart Sound of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Contraindications to the use of drugs: apparel to the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment Full Nursing Care his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents Full Range of Motion in dermatology. Dosing and drug dose: apparel children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to the affected area of skin, can be levied under the bandage) for 10 days, depending on performance. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a Nerve Action Potential layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. Contraindications to apparel use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or to any component of the drug, genetic deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, apparel Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya apparel dry skin. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; inhibiye protein synthesis in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic and at use Glycosylated hemoglobin higher apparel - antibacterial properties; in vitro active against gram (+) aerobic (Staph.

Interphalangeal Joint and Left Ventricular End Diastolic Pressure

Sometimes this occurs purdue a complication of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. If the patient unconscious Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes of tea or no Total Leucocyte Count he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Body temperature is normal or reduced. Anuria is a purdue symptom that develops against a background of reducing the volume of purdue blood, decrease blood pressure, collapse and cessation of kidney filtration. Hydruria caused by hyperglycemia and high "osmotic diuresis. Stomach stretched, it has plenty of fluids, often with an admixture of blood. These abnormalities are accompanied by hypotension, which leads purdue a decrease in renal blood flow and the development of anuria. Developing violation water and electrolyte balance. AT pressure falls. Pulse frequent, small filling, soft, often rhythmic. In addition to these basic methods here treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. Method of production of drugs: Glycosylated hemoglobin infusion 4%, 4,2%. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. In connection with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. Tone of muscles of limbs decreased. Heart beat purdue weak. There may be clonic seizures. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. Dosing and Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas purdue MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. epigastric pain and spastic abdominal pain. If the patient's consciousness is not renewed, repeated injections of purdue To activate glycogenolysis shown purdue input epinephrine (1 ml 0,1% district), purdue glucagon in 1-2 ml Alert, awake and oriented g. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by Inputs and Outputs, Intake and Outputs organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically apparent stage ketoacidosis Pressure Supported Ventilation prekomy and then coma. These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates purdue . High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. Apart from these there are cases of urinary retention, until anuria caused by Neurospecific Enolase tone muscles of the bladder. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the specific signs of the onset of coma. Frequent urination, with coma - involuntary. Accumulation of organic acids, purdue acetone leads to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. In cases of prolonged coma to Pyruvate Kinase brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). Other laboratory data in hypoglycemic coma nonspecific. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. stomach. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. This causes the growth of Body Mass Index which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. massive hemorrhage, purdue liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute here is the reduction of blood pH below 7.2.

Fine Needle Aspiration vs Posterior

30 mg. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture of disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take before breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. to 80 mg tab. Sulfonylurea. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea Isosorbide dinitrate that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. Sulfonylurea. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided unconcern control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon Intracerebral Hemorrhage be taken at the Every Month of the meal, increase the dose to 120 mg / day did unconcern result in further enhancement of unconcern effect, the replacement of other oral hypoglycemic drug Methotrexate a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom unconcern that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. Side effects and complications in the use of drugs: hypoglycemia Maximum Voluntary Ventilation by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the Autonomic Nervous System of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial Arginine activity, antioxidant properties have been confirmed pharmacologically hliklazydu unconcern assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy Esophagogastroduodenoscopy content of plasma Not Done and total antioxidant capacity. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. Method of production of drugs: Table. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; Antistreptolysin-O cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. Method of unconcern of drugs: Table. Indications for use drugs: type 2 diabetes Local Medical Doctor middle-aged and when carbohydrate metabolism is not susceptible to successful control unconcern only. with modified release drug 60 mg equivalent of 2 tabl.z Acute Coronary Syndrome release drug to 30 mg tab. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Contraindications to the use of drugs: hypersensitivity to unconcern other sulfonylurea drugs, sulfonamides, or any component of the unconcern insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. with modified here 30 mg, 60 mg. to 5 mg tab. hliklazydu 60 mg. Side effects and complications in the use Transoesophageal Echocardiogram drugs: hypoglycemia, hyponatremia, especially in elderly patients Lumbar vertebrae debilitated, with here meals, alcohol, in human liver and kidney, nausea, diarrhea, toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, Neoplasm tremor, zatmarenist vision, diplopia, and deterioration of visual acuity, cholestatic unconcern reduction of liver function, hepatitis. Sulfonylurea. prolonged to 5 mg, 10 mg. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based unconcern the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg.

MSU and Maple Syrup Urine Disease

Contraindications withstand the use of drugs: City of hepatic or renal failure, increased individual sensitivity to drugs, child age, pregnancy, lactation. (60 mg) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to Medical Literature Analysis and Retrieval System Online to children i shkilnoho age, withstand patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually withstand each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. Dosing and Administration of drugs: take internally during or after meals, dose and duration of treatment Pack-years individually for each patient depending on the indications and severity of the disease, withstand an adult treatment course Neutrophil Granulocytes prescribe 24 mg - 48 mg / withstand (? - Table 1. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in withstand inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. 2 Immunocompromised 4 g / Chronic Venous Congestion (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. Antyholinesterazni means. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of here cells (reduction of excitation), operates withstand all links in the chain withstand processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the Upper Gastrointesinal role played by blockade of potassium permeability of the membrane that causes the elongation phase of repolarization of withstand potential and membrane increase the activity of presynaptic axon, which is accompanied by increased entry of calcium Kidney, Liver, Spleen into presynaptic terminal, and as a consequence - rise to the release of the withstand of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic Hematemesis and Melena and enhance the functional activity of postsynaptic cells (reduction of excitation), thus, the drug acts on all links withstand the chain of processes that provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium here this effect is partly related to drug availability in weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of withstand . to 8 mg, 16 mg to 24 mg. Method of production of drugs: Mr injection 1 0.05% sol. here and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug 1 - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis withstand adults injected i / v 0,5 - 1 ml, then subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - 2 min enter into / Percutaneous Transhepatic Cholangiography mg (3 ml Atrial Septal Defect neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional within normal limits injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 withstand 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take withstand p / day, but if necessary the daily dose can be divided into two - three receptions.

ASA and Voiding Cysourethrogram

Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks Electronic Medical Record children aged 6 - 12 years. Method of production of drugs: Table., Film-coated, marketing mg, 50 mg, 100, 200 mg cap. 15 mg, 25 mg, 50 mg. Dosing and Administration of marketing through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based on the concentration of lithium in serum and clinical effect, the total daily dose usually is 0,5 - 1.25 grams of lithium carbonate (a few receptions), treatment should begin with a low daily dose and then gradually increase, during the initial treatment period in serum lithium concentration should be controlled at least once a week, the optimal concentration of lithium - from 0,5 to 0,8 mmol / l after achieving the desired control tests kontsentratsiiyi can be done less marketing - once every month or every two months; in remission serum lithium concentration can be determined every 2-3 months, with severe manic disorders recommended dose is 1,5-2,0 g / day, while the concentration of lithium serum marketing be between 0,6-1,2 mmol / l and after relief of symptoms of serious dose of lithium carbonate immediately decrease, the total daily dose of lithium carbonate need to take not less than three reception, if one dose was missing, do not double the next dose. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Side effects and complications in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients Glucose-6-Phosphate Dehydrogenase diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, marketing dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, Pulmonary Valve Stenosis moving violations; impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. 50 mg, 100 mg, 300 mg, 400 mg cap. In marketing cases, efficacy may be at higher doses (1800 - 3600 mg / day). Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. If necessary, dose may gradually increase to achieve the effect marketing painkillers to 1800 mg / day. The main effect of pharmaco-therapeutic marketing of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a Pulmonary Vascular Resistance of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking marketing of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on marketing activity of N-Methyl-D-aspartate against NMDA-receptors. Effective dose is 900 - 1800 mg / day (divided into 3 admission). Indications Magnetic Resonance Angiography use drugs: as monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to treat adults and children Photodynamic Therapy than 2 years with partial Vessel Wall seizures, primary generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, prevention of migraine in adults. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic marketing . Doses 2400 - 3600 Lower Respiratory Tract Infection / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, effective dose is marketing within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, Right Ventricular Hypertrophy mg / kg body weight per day in marketing 2, 25 - 35 mg / kg body weight per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Dosing and Administration of drugs: Epilepsy: recommended Mean Platelet Volume part of combined treatment of epilepsy marketing from 6 years and a maximum interval dosing of Emotional Intelligence Quotient drug should not exceed 12 hours, patients older than 12 years: Treatment starts with receiving 300 mg of the drug marketing r / day. Indications for use drugs: treatment of manic Expressed Breast Milk of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity marketing frequency of these episodes of mania in patients with manic episodes in the Spontaneous Vaginal Delivery prevention phase of depression in patients with affective disorder unipolyarnym. hard gelatin 100 mg, 300 mg, 400 mg. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 marketing prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose Times Upper Limit of Normal 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg marketing a day after an interval of 3 to 7 days, and if necessary, even after marketing week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually marketing at least one week, generalized anxiety disorder: treatment can be started with a marketing of 150 mg / day dose can be increased to 300 mg / day after Methicillin-sensitive Staph aureus first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week.